Tekla Capital Management’s United Therapeutics UTHR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2023
Q2
$9.15M Sell
41,465
-19,735
-32% -$4.36M 0.36% 63
2023
Q1
$13.7M Sell
61,200
-53,877
-47% -$12.1M 0.52% 43
2022
Q4
$32M Sell
115,077
-2,300
-2% -$640K 1.21% 25
2022
Q3
$24.6M Buy
117,377
+45,171
+63% +$9.46M 1.01% 30
2022
Q2
$17M Hold
72,206
0.67% 38
2022
Q1
$13M Sell
72,206
-29,531
-29% -$5.3M 0.45% 53
2021
Q4
$22M Sell
101,737
-43,203
-30% -$9.34M 0.71% 41
2021
Q3
$26.8M Buy
144,940
+5,502
+4% +$1.02M 0.86% 34
2021
Q2
$25M Buy
139,438
+75,925
+120% +$13.6M 0.81% 31
2021
Q1
$10.6M Hold
63,513
0.37% 71
2020
Q4
$9.64M Hold
63,513
0.34% 82
2020
Q3
$6.42M Hold
63,513
0.24% 92
2020
Q2
$7.69M Hold
63,513
0.29% 73
2020
Q1
$6.02M Buy
63,513
+9,419
+17% +$893K 0.27% 73
2019
Q4
$4.77M Hold
54,094
0.18% 106
2019
Q3
$4.31M Hold
54,094
0.19% 91
2019
Q2
$4.22M Buy
54,094
+12,833
+31% +$1M 0.17% 99
2019
Q1
$4.84M Hold
41,261
0.2% 96
2018
Q4
$4.49M Hold
41,261
0.19% 89
2018
Q3
$5.28M Hold
41,261
0.19% 89
2018
Q2
$4.67M Hold
41,261
0.18% 95
2018
Q1
$4.64M Buy
41,261
+25,041
+154% +$2.81M 0.18% 94
2017
Q4
$2.4M Sell
16,220
-27,741
-63% -$4.1M 0.09% 120
2017
Q3
$5.15M Hold
43,961
0.18% 89
2017
Q2
$5.7M Hold
43,961
0.21% 84
2017
Q1
$5.95M Sell
43,961
-49,139
-53% -$6.65M 0.23% 81
2016
Q4
$13.4M Hold
93,100
0.57% 40
2016
Q3
$11M Hold
93,100
0.42% 57
2016
Q2
$9.86M Hold
93,100
0.4% 60
2016
Q1
$10.4M Hold
93,100
0.44% 57
2015
Q4
$14.6M Sell
93,100
-89,500
-49% -$14M 0.53% 39
2015
Q3
$24M Buy
+182,600
New +$24M 0.86% 23